• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

NIH resumes critical grant-making process after federal communications freeze at HHS

by February 7, 2025
written by February 7, 2025

The National Institutes of Health (NIH) will resume important meetings and travel associated with the critical grant-review process amid an agency-wide communications freeze at the Department of Health and Human Services (HHS).

While the agency is working its way back to normalcy, its operations are still not completely back to what they were before President Donald Trump took office. The advisory council and scientific review meetings associated with the NIH’s grant-making process, in which outside scientists provide a final grant review and strategic advice before the finalization of a new program, have continued but will not yet meet in open session.  

When Trump took office, he initiated a freeze on external communications at HHS and all of its sub-agencies. Earlier this week, HHS spokesman Andrew Nixon said that ‘several types of external communications’ are no longer subject to the pause, and ‘all HHS divisions have been given clear guidance on how to seek approval for any other type of mass communication.’

NIH is currently taking things day-by-day to ensure they are meeting their obligations under the Federal Advisory Committee Act, which governs the operation of federal advisory committees and emphasizes public involvement through open meetings and reporting.

Last week, NIH director Matthew Memoli sent a letter to staff seeking to clarify the ongoing communications pause. According to Memoli, the freeze had been issued to ‘allow the new team to set up a process for review and prioritization,’ but noted that due to ‘confusion on the scope of the pause’ he wanted to provide additional guidance.

In addition to halting announcements, press releases, website and social media posts, new guidance, and new regulations, the freeze also halted public appearances and travel by agency officials, and prohibited new purchases or service requests related to agency work. The move caused anger and confusion among both HHS officials and those in the broader medical community, particularly due to the potential pause of critical health research.

In his memo to staff, Memoli clarified that any research or clinical trials initiated before Jan. 20 can keep going ‘so that this work can continue, and we do not lose our investment in these studies.’ Officials working on these studies may also purchase any ‘necessary supplies’ and conduct meetings related to such work. Although new research projects are still prohibited, NIH staff were told they could continue submitting papers to medical journals and can communicate with those journals about submitted work.

Travel and hiring for such work can continue as well, Memoli indicated, but his office must grant specific exemptions for new hires as Trump also initiated a freeze on the hiring of new federal civilian employees across all agencies during his first week in office. Routine travel planned for after Feb. 1 ‘does not need to be canceled at this time,’ Memoli added. Patients receiving treatment at NIH facilities can also continue to do so. 

NIH can also submit documents to the Federal Register and send correspondence to public officials.

While the pause at HHS has caused a firestorm of concern and criticism, Dr. Ali Khan, a former Centers for Disease Control and Prevention scientist who is now the dean of the University of Nebraska’s school of public health, told the Associated Press that such pauses are not unusual. Khan said concern is only warranted if the pause was aimed at ‘silencing the agencies around a political narrative.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
The Hitchhiker’s Guide to House Republicans releasing their tax and spending cut plan
next post
FBI agents’ association ‘optimistic’ about AG Bondi despite early controversy with Trump administration

related articles

Elon Musk sports black eye at farewell presser...

May 30, 2025

Biden says he could ‘beat the hell out...

May 30, 2025

Donald Trump fires National Portrait Gallery director for...

May 30, 2025

‘American hero’ or ‘failure’: Elon Musk’s DOGE departure...

May 30, 2025

Unfinished Business: The budget cuts Musk couldn’t complete...

May 30, 2025

Alleged attempt to impersonate White House chief of...

May 30, 2025

Inside the late-night drama that led to Trump’s...

May 30, 2025

I’m a physician and I’m worried that our...

May 30, 2025

President Trump teases ‘last day, but not really’...

May 30, 2025

Trump denounces court’s ‘political’ tariff decision, calls on...

May 30, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump admin cuts additional $1M in federal funding for ‘transgender animal’ experiments

    March 25, 2025
  • Judge denies Democrat-led effort to block DOGE access, citing lack of proven harm

    February 18, 2025
  • Stellar and Bitcoin Cash: Stellar bounced back to EMA 200 

    September 3, 2024
  • Flashback: Biden admin bragged about ‘quieter’ Middle East one week before attack on Israel

    September 29, 2024
  • Trump envoy doesn’t believe Putin wants to take over Europe

    March 23, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (4,731)
  • Investing (624)
  • Stock (775)

Latest Posts

  • House GOP leaders demand accountability on Trump assassination attempt: ‘So many questions’

    July 18, 2024
  • Dow rallies 700 points for best day in more than a year, Russell 2000 small-cap index jumps 3%

    July 17, 2024
  • Kamala Harris praises Biden’s legacy in first remarks since announcing 2024 bid

    July 22, 2024

Recent Posts

  • Biden calls Speaker Johnson ‘dead on arrival’ in odd response to criticism of proposed radical SCOTUS changes

    July 30, 2024
  • Putin’s ‘Fog of War’ missile confuses experts, but that’s his plan

    November 26, 2024
  • Long RNA: Avidity Biosciences Shows Strength Amid Market Turmoil

    August 6, 2024

Editor’s Pick

  • PSNY Stock: Unpacking Polestar’s Financial Rollercoaster

    August 5, 2024
  • Trump’s pick to lead NIH, Dr. Jay Bhattacharya, confirmed by Senate in party-line vote

    March 26, 2025
  • Election fraud alert: Steps to safeguard your vote

    August 30, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock